Topic

History of Pharmacy and Apothecaries

Pharmacy has no single birthplace or unbroken path to the modern dispensary. Across the Mediterranean, West and South Asia, and China, people recorded, traded, prepared, and judged medicinal substances long before “pharmacist” became a regulated occupation. From the eighth century onward, specialized drug sellers are well documented in Islamic societies; in early modern Europe, apothecaries worked beside household healers, grocers, surgeons, physicians, and itinerant vendors. Nineteenth-century chemistry and factories then moved much manufacture away from the shop, while twentieth-century disasters made evidence of safety and efficacy a legal concern.

Pharmacy history is therefore more than a story of increasingly standardized drugs. It is the history of who could make and sell medicines, whose knowledge and labor supplied them, how authorities tried to control quality, and why a product made to a consistent formula could still be ineffective, dangerous, or inaccessible.

Scope: Selected traditions from antiquity to the later twentieth century, with detailed case studies from Abbasid cities, Song China, Britain, and the United States
Key themes: Materia medica, compounding, household practice, shops, pharmacopoeias, empire, professional boundaries, manufacture, labeling, safety, and efficacy
Important limit: This is a comparative guide, not a complete global chronology; occupational titles and legal powers differed sharply by place and period

Read the topic Back to topics

Origins And Traditions

Medicines were organized in many traditions before pharmacy became a profession

Historians use materia medica for bodies of knowledge about medicinal materials and their preparation. The Latin phrase comes from the title by which a first-century Greek work became known, but comparable genres developed in other languages and medical systems. A medicinal text is evidence of what an author or compiler thought worth recording; it is not a complete inventory of everyday treatment, nor proof that every recorded remedy worked.

Mediterranean texts classified materials and recipes

Pedanius Dioscorides, from Anazarbus in Roman Cilicia, composed the five-book Greek work later called De materia medica in the first century CE. It discussed plant, animal, and mineral drugs, their preparation, adulteration, and uses. Copies and translations circulated for roughly fifteen centuries, including in Byzantine, Arabic, and Latin settings. The second-century physician Galen of Pergamon likewise described compound medicines; “galenical” later became a pharmaceutical term for preparations made by extracting or compounding natural materials. Neither author was a modern pharmacist, and their therapeutic claims belonged to ancient medical theories rather than present-day clinical testing; John M. Riddle’s scholarly account of Dioscorides documents the work’s scope and transmission.

South Asian drug knowledge belonged to changing medical cultures

Ayurvedic compendia associated with Caraka and Suśruta contain extensive discussions of substances, formulations, diet, poisons, and preparation. Their surviving texts were layered and revised over long periods, so a single confident composition date is misleading. Ayurveda was also not a timeless, purely Hindu system: Buddhist, Jain, courtly, regional, and later colonial institutions shaped its practice. The modern category “alternative medicine” should not be projected backward onto a tradition that long held different social and intellectual positions in the Indian subcontinent, as M. R. Raghava Varier emphasizes in his critical history of Ayurveda.

Chinese bencao joined classification to state provision

Chinese bencao works recorded medicinal materials, properties, combinations, and uses. The Shennong bencao jing survives as a compilation associated with the Eastern Han period (25–220 CE), while the Tang government commissioned the Xinxiu bencao in 659. Zhao, Guo, and Brand provide a concise chronology of the bencao literature. These were not simply Chinese versions of a European pharmacopoeia. In 1076, during the Northern Song reforms, the government established an Imperial Pharmacy intended partly to intervene in drug markets; it later sold prepared formulas as well as individual ingredients through multiple branches. The historian Asaf Goldschmidt cautions in his study of the institution that its effect on medical practice is harder to establish than its administrative growth.

These examples show parallel concerns—identification, substitution, toxicity, dose, storage, and reproducible preparation—without making the traditions interchangeable. Their disease categories and explanations of bodily action were historically specific, and longevity of use is not, by itself, evidence of safety or effectiveness under modern standards.

Islamic Societies

Specialized drug sellers emerged in a multilingual Abbasid medical world

After the Abbasid caliphate was established in 750, Baghdad became a major center for translation and medical writing. Muslim, Christian, Jewish, and other scholars worked with Greek, Syriac, Persian, and Indian materials. The movement was not simple “preservation”: translation changed vocabulary and organization, while authors added drugs obtained through long-distance trade and their own medical experience. Works associated with al-Razi and Ibn Sina later circulated far beyond the regions in which they were written.

Sources from the eighth and ninth centuries describe specialized drug shops and sellers, often called saydalani or sayadila. They handled simples—single medicinal materials—and compound preparations such as syrups, electuaries, ointments, and aromatic waters. Markets and hospitals created settings for this expertise, and officials sometimes inspected weights, ingredients, and sellers. Yet “the separation of pharmacy from medicine” is too neat a formula: physicians could compound drugs, sellers could advise customers, and governmental control varied. Sami Hamarneh’s influential 1962 article documented professional specialization but also noted the absence of a firm legal boundary between prescribing and dispensing.

The National Library of Medicine’s medieval manuscript survey is useful for this transmission history, but surviving learned books privilege literate authors and collectors. They reveal less about patients, family care, oral knowledge, or the routine work of shop assistants. Illustrated manuscripts can also be later, idealized representations rather than eyewitness pictures of early Abbasid shops.

Shop, Household, And Guild

The European apothecary was a maker, merchant, and sometimes medical practitioner

“Apothecary” did not name the same occupation everywhere. Municipal statutes, guilds, courts, and medical corporations repeatedly renegotiated whether an apothecary could prescribe, only dispense a physician’s order, sell groceries, or treat patients directly.

A shop turned a written recipe into material work. Apprentices and employees selected and cleaned ingredients, detected substitution, weighed with local systems, ground and sifted solids, controlled heat, distilled liquids, and formed pills, plasters, syrups, powders, and ointments. Jars and drawers made goods visible, but much knowledge remained tacit: texture, smell, color, season, and response during heating could matter as much as the words in a formula. Stock depended on gardens, grocers, ports, wholesalers, credit, and the shelf life of perishable materials.

The shop never monopolized medicine-making. Early modern English manuscript “receipt books”—the period word for recipe collections—show men and women exchanging, adapting, and testing medical and culinary preparations in households. Elaine Leong describes this as collective household knowledge in Recipes and Everyday Knowledge, not a lesser imitation of professional practice. Such manuscripts are also socially selective: surviving examples disproportionately document literate families with the resources to preserve books. They nonetheless correct the false picture of a male apothecary replacing domestic healers overnight.

London, 1617–1618: a corporate settlement, not a universal beginning

James I chartered the Worshipful Society of Apothecaries as separate from the Grocers’ Company in 1617. In 1618 the Royal College of Physicians issued the Latin Pharmacopoeia Londinensis, backed by royal proclamation, to govern authorized drugs and preparations. The first May edition was suppressed and replaced later that year. The book is a valuable primary source for official formulas and institutional ambition, but it is prescriptive: it cannot by itself prove what every London shop stocked, prepared, or sold. Wellcome Collection provides the digitized first edition and catalogue record.

Apothecaries also became general practitioners

English apothecaries had long advised and treated customers as well as dispensing. In the 1704 Rose case, the House of Lords protected this role against the College of Physicians’ challenge. During the eighteenth century, “chemist and druggist” became another important retail identity, while “apothecary” increasingly described a medical practitioner. Modern British “pharmacist” and “general practitioner” therefore descend from an untidy occupational field, not a clean ancient division between prescriber and dispenser. The Royal Pharmaceutical Society Museum traces these changing British occupational boundaries.

Commerce And Empire

Long-distance drug supply depended on unequal power and coerced labor

Early modern European pharmacies drew on materials carried through the Mediterranean, Atlantic, and Indian Ocean worlds. Drug merchants dealt in cinchona bark, opium, rhubarb, senna, spices, gums, metals, and animal products whose names and quality could change between producer and shop. Local and Indigenous experts supplied knowledge of collection and use, but European publications and commercial firms often reassigned authority to the collector, translator, or manufacturer.

This circulation was not benign exchange. Zachary Dorner’s archival study of Britain’s long eighteenth century connects apothecaries and medicine traders to colonial warfare, plantation production, and slavery. Medicines were manufactured in Britain for ships, armies, plantations, and colonial markets; they could be offered as care, rationed to preserve labor, or administered coercively. The growth of reliable long-distance packages thus belonged to imperial finance and extraction as well as to technical improvement.

Standards And Profession

Pharmacopoeias stabilized products while registers stabilized occupations

Official books made local formulas comparable

A pharmacopoeia specifies recognized substances and preparations; later editions increasingly added tests for identity, purity, and strength. The first Pharmacopoeia of the United States of America was prepared under a general medical convention and printed in Boston in 1820. The British Pharmacopoeia of 1864 replaced separate London, Edinburgh, and Dublin standards with a single national work. Such books could help expose adulteration and inconsistent strength, but a quality monograph was not a clinical trial and did not demonstrate that a listed treatment benefited patients. The 1820 US text and the British Pharmacopoeia’s account of its standards show how the contents and legal roles of such works changed.

British professionalization mixed public protection and self-interest

Chemists and druggists formed the Pharmaceutical Society of Great Britain in 1841 partly to defend a distinct occupation against medical reform. Its school opened in 1842. The Pharmacy Act 1852 created a voluntary register; the 1868 Act tied the sale of scheduled poisons to registration and examination more firmly. Education and control of poisons served public safety, while titles, membership, and market access also protected the profession’s status, as the RPS Museum’s institutional history records.

Credentials could include and exclude

The first compulsory British register included 223 women already working as pharmacists, yet the Society barred women from full membership until 1879. Employees and assistants likewise had fewer institutional rights than shop owners. Regulation did not merely recognize expertise; it decided which training, workplaces, and people counted as legitimate. Comparable processes unfolded differently in colonies and other nations, often privileging metropolitan qualifications over local systems of medicine.

Laboratory And Factory

Industrial medicines moved production away from the dispensing bench

Nineteenth-century pharmacists and chemists isolated potent constituents from older drug materials, including morphine from opium and quinine from cinchona. A purified substance could be weighed and assayed more consistently than a variable bark or resin, but greater potency also increased the consequences of dosing error, dependence, contamination, and misuse. “Active principle” was a productive laboratory idea, not proof that every whole remedy contained one simple curative essence. A Science History Institute case study of cod-liver oil shows how extraction, branding, and evidence could pull in different directions.

Wholesale drug houses expanded production, and chemical and dyestuff firms built research laboratories from the late nineteenth century. Tablets, capsules, ampoules, sealed packages, trademarks, and printed labels allowed a product to travel without the maker. Pharmacy did not become industrial in one step: local compounding, hospital dispensaries, small manufacturers, patent medicines, and large research firms overlapped for decades. A brand could promise uniformity, while advertising could turn uncertain or secret formulas into profitable commodities.

Mass production changed the pharmacist’s work rather than simply ending it. Purchasing and storing manufactured products, checking prescriptions and doses, preparing medicines unavailable in suitable forms, maintaining hospital supply, and identifying adverse effects became increasingly important. The balance between compounding, retailing, and clinical responsibility continued to vary among health systems.

Safety, Efficacy, And Law

Drug disasters exposed the limits of purity standards and professional trust

Twentieth-century regulation did not arrive as one complete system. Different laws addressed adulteration, labels, poisons, manufacturing, market access, safety, or efficacy, often only after existing powers failed visibly.

United States: labeling came before premarket proof

The Pure Food and Drugs Act of 1906 prohibited interstate commerce in adulterated or misbranded drugs and recognized official standards, but it did not require manufacturers to prove a new drug safe or effective before sale. In 1937, an “elixir” of sulfanilamide made with the toxic solvent diethylene glycol killed 107 people, many of them children. The Federal Food, Drug, and Cosmetic Act of 1938 then required evidence of safety for new drugs and authorized factory inspections. The sequence matters: a medicine could be consistently manufactured and truthfully named yet remain lethally unsafe. The FDA’s history of the 1938 Act documents both the earlier law’s limits and the disaster.

1962: efficacy became an explicit premarket requirement in the US

Thalidomide caused severe fetal harm after being marketed in Europe and elsewhere as a sedative, including for pregnant patients. It was not approved for sale in the United States. The 1962 Kefauver–Harris amendments required manufacturers to provide evidence of effectiveness as well as safety before US marketing and strengthened oversight of research and manufacturing. This was a major change, not a guarantee that all harms would be detected before widespread use. The FDA summarizes these legislative milestones.

United Kingdom: thalidomide accelerated comprehensive licensing

Britain initially responded with voluntary review through the Committee on Safety of Drugs in 1964. The Medicines Act 1968 established a comprehensive licensing framework covering manufacture, distribution, importation, and medicinal products; the statutory system took effect in 1971. Parliamentary debate is a revealing primary source for the government’s intended balance of safety, efficacy, access, professional judgment, and industry, but it is not neutral evidence that the law achieved every promise made for it. A later House of Commons Library briefing summarizes the enacted framework, while the 1968 Commons debate preserves contemporary claims and concerns.

Modern drug safety therefore depends on continuing surveillance as well as premarket testing. Clinical studies involve limited populations and durations; rare or delayed harms may appear only after wider use. This historical point is not individual medical advice: current questions about a medicine belong with qualified health professionals and current regulatory information.

Chronology

Selected turning points

First century CE: Dioscorides composes the Greek work later known as De materia medica in the Roman Mediterranean.
25–220 CE: the surviving Shennong bencao jing is associated with the Eastern Han era; its exact compilation history is complex.
659: the Tang government commissions the Xinxiu bencao, an official revision of Chinese medicinal knowledge.
Eighth–ninth centuries: specialized drug sellers and shops are documented in Abbasid cities amid translation, hospital, court, and market medicine.
1076: the Northern Song government establishes an Imperial Pharmacy, initially as an intervention in medicinal commerce.
1617–1618: London apothecaries receive a separate corporate charter, followed by the College of Physicians’ legally backed Pharmacopoeia Londinensis.
1704: the Rose case protects English apothecaries’ ability to treat patients as well as dispense medicines.
1820: a US medical convention publishes the first Pharmacopoeia of the United States of America.
1841–1868: the Pharmaceutical Society, its school, and successive Pharmacy Acts reshape education, registration, titles, and poison sales in Britain.
1864: the first British Pharmacopoeia creates common official drug standards for the United Kingdom.
Late nineteenth century: wholesale manufacture, alkaloid production, chemical research, tablets, brands, and chain retail increasingly separate medicines from the shop in which they are dispensed.
1906–1938: US federal control develops from adulteration and labeling law to premarket safety requirements after the sulfanilamide disaster.
1962–1971: the thalidomide disaster helps drive stronger efficacy, safety, manufacturing, and licensing systems in the United States and United Kingdom.

Interpretive Cautions

Four myths flatten pharmacy history

There was no single first pharmacist

Claims for the “first pharmacy” usually depend on a chosen definition: specialist seller, licensed shop, hospital dispensary, guild, public branch, or legally distinct profession. The answer changes with the definition and jurisdiction.

Standardization did not equal therapeutic proof

Fixed names and assays could improve identity, strength, and reproducibility. They could also reproduce an ineffective preparation very consistently. Legal demands for evidence of safety and efficacy arose later and remain distinct from pharmacopoeial quality standards.

The shop did not replace household medicine

Families, midwives, nurses, religious institutions, market sellers, and other healers continued to prepare and exchange remedies. Guild and licensing records make recognized male occupations easier to see than this dispersed labor.

Industrial pharmacy was not a simple triumph over tradition

Chemistry and mass manufacture enabled potent and reproducible medicines, but also concentrated commercial power and produced new risks. Colonial extraction, coerced labor, secrecy, aggressive promotion, addiction, and unequal access belong inside the history of pharmaceuticals, not outside it.

Reading Path

Where to go next

From Materia Medica to Modern Drugs
Follow medicinal substances through trade, extraction, testing, manufacture, and regulation.
History of Medical Botany
Examine identification, cultivation, illustration, colonial collecting, and plant-derived drugs.
History of Herbal Medicine
Place household remedies and learned plant traditions alongside pharmacy rather than treating them as identical.
History of Pain Relief and Aspirin
Use one drug history to compare natural materials, chemical modification, branding, and evidence.
History of Antibiotics and Penicillin
Trace laboratory discovery, collaborative development, wartime scale-up, access, and resistance.

References

Sources and further reading

Stuart Anderson, ed., Making Medicines: A Brief History of Pharmacy and Pharmaceuticals (Pharmaceutical Press, 2005)
A multi-author chronological history covering occupations, practice, industry, dosage forms, quality, and safety; bibliographic record at Wellcome Collection.
John M. Riddle, “Dioscorides (2), of Cilician Anazarbus,” Oxford Classical Dictionary (2016)
A concise scholarly account of the author, contents, organization, and transmission of De materia medica: doi:10.1093/acrefore/9780199381135.013.2232.
M. R. Raghava Varier, A Brief History of Āyurveda (Oxford University Press, 2020)
Uses textual, archaeological, and epigraphic evidence to place Ayurvedic knowledge in changing religious, regional, institutional, and colonial settings: doi:10.1093/oso/9780190121082.001.0001.
Zhongzhen Zhao, Ping Guo, and Eric Brand, “A Concise Classification of Bencao (Materia Medica),” Chinese Medicine 13 (2018): 18
Surveys the chronology and contents of major Chinese bencao works: doi:10.1186/s13020-018-0176-y.
Asaf Goldschmidt, “Commercializing Medicine or Benefiting the People—The First Public Pharmacy in China,” Science in Context 21, no. 3 (2008): 311–350
An archival study of the Imperial Pharmacy established during the Northern Song reforms and the uncertainty around its effects on medical practice: doi:10.1017/S0269889708001816.
Sami Hamarneh, “The Rise of Professional Pharmacy in Islam,” Medical History 6, no. 1 (1962): 59–66
A foundational, though older, article on specialized drug sellers, inspection, and porous professional boundaries in medieval Islamic societies: doi:10.1017/S0025727300026855.
National Library of Medicine, “Medieval Manuscripts: Arabic Legacies”
An institutional overview of Abbasid translation and the movement of Arabic medical texts; useful for manuscript context rather than a complete social history of pharmacy: nlm.nih.gov.
Elaine Leong, Recipes and Everyday Knowledge: Medicine, Science, and the Household in Early Modern England (University of Chicago Press, 2018)
A major study of collective recipe-making, testing, and knowledge exchange in early modern households: doi:10.7208/chicago/9780226583525.001.0001.
Folger Shakespeare Library, “Recipe Books at the Folger Shakespeare Library”
A catalogue of digitized early modern manuscript recipe books. These are primary sources for recorded household and institutional recipes, not proof of how commonly each preparation was made or used: folger.edu.
Royal College of Physicians, Pharmacopoeia Londinensis (London, 1618)
The first, suppressed edition is digitized by Wellcome Collection. It records an official and coercive standard, not a neutral survey of actual shop practice: Wellcome Collection; historical context from the RCP Museum.
Royal Pharmaceutical Society Museum, “The History of the Royal Pharmaceutical Society”
An institutional account of chemists and druggists, the Society’s formation, education, Pharmacy Acts, corporate retail, and women’s membership. Its commemorative perspective is supplemented here by independent scholarship: RPS Museum.
Zachary Dorner, Merchants of Medicines: The Commerce and Coercion of Health in Britain’s Long Eighteenth Century (University of Chicago Press, 2020)
Connects pharmaceutical manufacture and trade to empire, finance, warfare, plantation slavery, and coerced administration: University of Chicago Press.
The Pharmacopoeia of the United States of America (Boston, 1820)
A digitized primary source prepared under the authority of a general medical convention; the catalogue identifies its historical introduction, materia medica, secondary list, and preparations: National Library of Medicine scan via Wikimedia Commons.
British Pharmacopoeia, “What Is the BP?”
The official account of the British Pharmacopoeia’s quality standards since 1864 and their legal role: pharmacopoeia.com.
Science History Institute, “The Man with a Fish on His Back”
A collection-based case study of nineteenth-century “active principles,” proprietary products, advertising, and changing evidence around cod-liver oil: sciencehistory.org.
US Food and Drug Administration, “80 Years of the Federal Food, Drug, and Cosmetic Act” and “Laws Enforced by FDA”
Official histories of the limits of the 1906 law, the 1937 sulfanilamide disaster, the 1938 safety requirement, and the 1962 efficacy amendments: 1938 Act history and legislative milestones.
UK Parliament, Medicines and Medical Devices Bill 2019–21, House of Commons Library Briefing Paper CBP-8699 (2020), pp. 31–33
A retrospective legislative account of thalidomide and the Medicines Act 1968: parliament.uk. For contemporary governmental aims and debate, see the 15 February 1968 Commons debate.